Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial.
Mikkel ØstergaardJoseph WuLara FallonSarah P SherlockCunshan WangDona FleishakerKeith S KanikWalter P MaksymowychPublished in: Rheumatology and therapy (2023)
ClinicalTrials.gov registry (NCT01786668).